29LOW

CAN

CANN GROUP FPO [CAN]
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
Healthcare · ASX Small Cap
$0.0060 +0.0%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical29
Catalyst51
Sentiment50
Fundamental37
Momentum28
Risk Gate22
Get alerts when CAN's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track CAN — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Volume surging at 2.6x normal while price falls — heavy selling pressure
  • Lagging the Small Ords index — relative strength of 0.84, underperforming its peers
  • Critical cash runway (0.7 quarters)
  • Low P/S ratio (0.8x)
  • Revenue in sharp decline (-30%)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (0% of range)
  • Micro-cap ($5-20M) - high risk
  • Capital raise activity (2 events)
  • Dilution velocity warning (2 raises recently)
  • Strong return on equity (73%)
  • Healthy profit margins (130%)
  • Sentiment is mixed — no strong consensus either way
  • Altman Z-Score distress zone (-0.16 < 1.81, low-confidence approx)
  • Elevated dilution risk (2 recent capital raises)
  • Penny stock risk ($0.006)
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 43% over the past year
  • Revenue declining at -30% — the top line is shrinking
  • The bigger volume days are the down days — volume-weighted momentum is negative (-0.47%/day)
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about CAN
"What's driving CAN's score?" "How does CAN compare to peers?" "Key risks for CAN?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Change in substantial holding
NONE Cleansing Notice
NONE Notification regarding unquoted securities - CAN

Recent ASX Announcements

2026-03-20 Change in substantial holding
2026-03-18 Cleansing Notice
2026-03-18 Notification regarding unquoted securities - CAN
2026-03-18 Cleansing Notice
2026-03-18 Application for quotation of securities - CAN

Key Metrics

$9.6M
Market Cap
3.1M
Avg Volume
2.6x
Vol Ratio
$0.01 — $0.03
52-Week Range
N/A
Short Interest
N/A
Cash Runway
72.6%
ROE
130.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSneutralEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 82%
LLeader vs LaggardlaggardRS: -7
IInstitutional SponsorshipweakInst: 7%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #116 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:CAN vs ATXCAN vs PNVCAN vs IMM
Scout Pro — Deeper Analysis for CAN
Try Pro free for 30 days
Share this analysis

Track CAN and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required